Opus Capital Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$251K Buy
+958
New +$253K 0.02% 124
2026
Q2
– Sell
-686
Closed -$203K – 148
2026
Q1
$203K Buy
+686
New +$204K 0.02% 129
2025
Q4
– Sell
-826
Closed -$223K – 136
2025
Q3
$223K Sell
826
-48
-5% -$13.1K 0.03% 125
2025
Q2
$241K Hold
874
– – 0.03% 112
2025
Q1
$232K Sell
874
-41
-4% -$10.1K 0.03% 111
2024
Q4
$212K Sell
915
-38
-4% -$8.74K 0.03% 111
2024
Q3
$210K Buy
+953
New +$197K 0.03% 114
2024
Q2
– Sell
-981
Closed -$211K – 118
2024
Q1
$211K Buy
+981
New +$206K 0.03% 115

Other funds holding CME

Opus Capital Group's CME Position: Q3 2026 in Review

Opus Capital Group opened a new position in CME Group (CME) in Q3 2026: 958 shares worth $251K. The stake represents 0.02% of the portfolio and ranks #124 among its holdings. This is a return to the name: Opus Capital Group previously reported a position in CME as recently as Q1 2026.

Opus Capital Group first reported a position in CME in Q1 2024 and has held it in 8 quarters since. 945 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Opus Capital Group held 958 shares of CME Group worth $251K as of Q3 2026.
  • CME Group was a new Opus Capital Group position in Q3 2026.
  • CME Group made up 0.02% of Opus Capital Group's portfolio in Q3 2026, its #124 holding.
  • Opus Capital Group first reported a position in CME Group in Q1 2024 and has held it in 8 quarters since.
  • 945 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Opus Capital Group's 13F filing for Q3 2026, filed 30 Oct 2026.